Trials / Completed
CompletedNCT05158686
Use of Drug-Coated Balloon to Improve Recanalization of a Coronary Chronic Total Occlusion After Failed Angioplasty
Use of Drug-Coated Balloon to Improve Recanalization of a Coronary Chronic Total Occlusion After Failed Angioplasty: The IMPROVED-RECTO Trial.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 44 (actual)
- Sponsor
- Ignacio J. Amat Santos · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Observational retrospective registry to compare effectiveness of paclitaxel-coated vs. non coated balloon angioplasty proximal to a Chronic Total Occlussion (CTO) after failed revascularization. Primary objective is to determine success rate after repeated percutaneous coronary intervention of a CTO 3 to 6 months after paclitaxel-coated balloon angioplasty proximal to the persistent lesion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Paclitaxel-coated Balloon dilation angioplasty | Paclitaxel-coated ballon dilation angioplasty proximal to CTO lesion after failed percutaneous recanalization |
| DEVICE | Non-coated Balloon dilation angioplasty | Non-coated ballon dilation angioplasty proximal to CTO lesion after failed percutaneous recanalization |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2020-10-01
- Completion
- 2021-12-01
- First posted
- 2021-12-15
- Last updated
- 2022-04-22
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05158686. Inclusion in this directory is not an endorsement.